GSK helps to fund the creation of thousands of meningitis signs and symptoms cards
Pictured: A statue of meningitis survivor Liam Doyle, created as part of our 30th anniversary exhibition at the RHS Chelsea Flower Show in 2016. This is now located permanently at GSK's plant in Siena, Italy, where the meningitis vaccine Bexsero is manufactured.
Since 2021, GSK have funded the printing costs for thousands of Meningitis Now signs and symptoms cards. These cards are vital to our awareness raising activities and are distributed to new parents, childcare nurseries, schools, businesses, healthcare organisations and at our events.
Knowing the signs and symptoms of meningitis and septicaemia and what action to take if you suspect the disease really can save lives. During our 35-year history, we have distributed more than 22 million cards. The funding that we receive from GSK have ensured that we will reach even more people with this potentially critical information.
About GSK
GSK is one of the world’s leading research-based pharmaceutical and healthcare companies that prioritises innovation in vaccines and specialty medicines. GSK focusses on four therapeutic areas: infectious diseases, HIV, immunology/respiratory, and oncology. Their mission is to maximise the opportunities to prevent and treat disease and improve the quality of human life by enabling people to do more, feel better and live longer.
GSK and Meningitis Now
Since 2011, GSK have donated over £200,000 towards a number of Meningitis Now awareness projects and support services, helping to make a meaningful difference to our fight against this devastating disease.
Meningitis Now has utilised donations from GSK to register nearly 500 nurseries and childcare providers across the UK to receive our Meningitis Awareness Recognition Mark (MARM). Funds from GSK have also helped us to support more than 100 young people through our Believe and Achieve programme.